Progress Towards a Vaccine Against Enterotoxigenic Escherichia Coli
Overview
Authors
Affiliations
A variety of approaches are being investigated in the development of a vaccine against enterotoxigenic Escherichia coli (ETEC). These approaches include purified fimbriae vaccines, toxoid vaccines, live attenuated E. coli vaccine strains and ETEC antigens expressed in carrier organisms. Studies of the pathogenesis and immune response to ETEC indicate that development of a vaccine against human ETEC is a realistic goal but considerable work remains before this goal is realized.
Zheng J, Zhang Z, Li S, Liu X, Yuan S, Wang P World J Gastroenterol. 2005; 11(22):3411-8.
PMID: 15948247 PMC: 4315996. DOI: 10.3748/wjg.v11.i22.3411.
Vu-Khac H, Holoda E, Majerciak M, Gaspar G, Pilipcinec E Folia Microbiol (Praha). 2004; 49(1):59-63.
PMID: 15114867 PMC: 7090526. DOI: 10.1007/BF02931647.
Fleckenstein J, Lindler L, Elsinghorst E, Dale J Infect Immun. 2000; 68(5):2766-74.
PMID: 10768971 PMC: 97486. DOI: 10.1128/IAI.68.5.2766-2774.2000.
Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli.
Fleckenstein J, Kopecko D, Warren R, Elsinghorst E Infect Immun. 1996; 64(6):2256-65.
PMID: 8675335 PMC: 174064. DOI: 10.1128/iai.64.6.2256-2265.1996.
Wu S, Pascual D, Vancott J, McGhee J, Maneval Jr D, Levine M Infect Immun. 1995; 63(12):4933-8.
PMID: 7591160 PMC: 173709. DOI: 10.1128/iai.63.12.4933-4938.1995.